Examiner Xiaobei Wang

Grant ratio: 56.0% (34th percentile in Art Unit 1784 among examiners with at least 20 applications). Average office actions per grant: 2.65. Most common rejection type: §103.

Recently active Last office action in data: August 2026
Grant ratio 56.0%
Average office actions / grant 2.65
Compared with Art unit About average
Compared with Work group Very easy
Compared with Technology center About average
Compared with USPTO About average

Examiner record

Examiner ID
85956
Primary art unit
1784
Work group
1780
Technology center
1700
Applications
727
Granted applications
407
Examiner phone
(571) 270-5705
Supervisor
Humera Sheikh
Supervisor phone
(571) 272-0604

Save this analysis

Download this examiner report.

Log in / Sign Up to export

Peer comparisons

GroupExaminersAverage grant ratioAverage office actions / grant
Art Unit 32 53.4% 2.07
Group 208 37.3% 2.71
Tech Center 1,792 44.3% 2.14
USPTO 16,475 52.7% 1.98

Office actions per application

Average office actions per application 2.51 1,822 office actions across 727 applications
Applications with office actions 99.2% 721 applications
Office actionsApplicationsShare of applications
No OA observed 6 0.8%
1 OA 202 27.8%
2 OAs 253 34.8%
3 OAs 108 14.9%
4 OAs 81 11.1%
5+ OAs 77 10.6%

Each application is counted once. “5+” includes all higher counts.

Grant history

0.0% 25.0% 50.0% 75.0% 100.0% 2009: 100.0% 2009 2012: 45.5% 2012 2013: 29.7% 2013 2014: 39.4% 2014 2015: 60.4% 2015 2016: 56.6% 2016 2017: 65.9% 2017 2018: 60.8% 2018 2019: 62.3% 2019 2020: 64.0% 2020 2021: 59.3% 2021 2022: 71.7% 2022 2023: 90.6% 2023 2024: 76.0% 2024 2025: 43.6% 2025 2026: 0.0% 2026

Recent ratios may be lower while applications remain pending.

Yearly counts
YearApplicationsGrantsGrant rate
200955100.0%
201211545.5%
2013371129.7%
2014331339.4%
2015533260.4%
2016533056.6%
2017412765.9%
2018513160.8%
2019533362.3%
2020503264.0%
2021593559.3%
2022604371.7%
2023534890.6%
2024503876.0%
2025552443.6%
20266300.0%

Rejections by office-action stage

Office-action stageActions observed§101§102§103§112
Action 1 721 0.3% 7.1% 83.8% 6.9%
Action 2 519 0.4% 4.2% 82.9% 10.2%
Action 3 266 0.0% 3.0% 88.7% 7.1%
Action 4 158 0.0% 1.9% 88.6% 8.2%
Action 5 77 0.0% 3.9% 92.2% 2.6%
Action 6 42 0.0% 2.4% 95.2% 0.0%
Action 7 23 0.0% 0.0% 87.0% 8.7%
Action 8 10 0.0% 10.0% 70.0% 20.0%
Action 9 4 0.0% 0.0% 100.0% 0.0%
Action 10 1 0.0% 0.0% 100.0% 0.0%

Section 101 rejections

Last 3 years 0.0% 0 of 344 office actions
All years 0.2% 4 of 1,822 office actions
Change -0.2 pts Percentage points

Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.

By year

0.0%
0.0%
0.0%
5.3%
0.0%
0.7%
2014: Alice
0.0%
0.0%
0.0%
0.0%
0.0%
2019: PEG
0.0%
0.0%
0.0%
0.0%
1.6%
2024: AI examples
0.0%
2025: August memo
0.0%
0.0%

Each bar is the percentage of office actions with a §101 rejection.

PTAB appeals

Matched decisions: 12. Merits outcomes: 7 affirmed, 0 affirmed in part, and 5 reversed.

Full reversal rate
41.7% 5/12 decisions
Full or partial reversal rate
41.7% 5/12 decisions
Median appeal duration
15.8 months
New grounds of rejection
0
Recent decisions
DecisionApplicationOutcomeIssues
Nov. 7, 2024 16/404,011 Reversed §102 · §103
Oct. 16, 2023 16/959,475 Affirmed §103
Sep. 22, 2023 16/616,260 Reversed §103
Mar. 30, 2023 15/542,636 Affirmed §103
Oct. 17, 2019 14/617,628 Affirmed §102 · §103 · §112
Sep. 19, 2018 12/723,559 Affirmed §103 · §112
Sep. 11, 2018 13/719,772 Affirmed §103
Jan. 29, 2018 12/869,860 Reversed §103
Aug. 2, 2017 12/680,556 Reversed §103
Mar. 29, 2017 12/869,859 Reversed §103 · §112
Dec. 2, 2016 14/045,129 Affirmed §103
Dec. 22, 2015 12/788,647 Affirmed §103

The examiner match uses the last recorded office action before the decision. Reversal rates exclude rehearings, remands, dismissals, and other decisions that did not reach the merits. Data through Aug. 27, 2026.

Job History

These are temporarily preserved for your convenience, but expire quickly for your security. We never save substantive inputs, pasted text, and/or uploaded files.

Jobs will appear here.